The possible effect of steady-state roflumilast on digoxin pharmacokinetics in healthy subjects - an open, randomized, two-period crossover design

*Please Note* The Study you are attempting to view was acquired from Takeda by AstraZeneca and was disclosed initially by Takeda per their Transparency Policies. More information regarding this study may be available by contacting [email protected].

An open-label, randomized, two-period crossover study in healthy subjects.